Healthcare startups from around the world are invited to apply for the second cohort of The Cure by Deerfield Middle East Health Accelerator (Cure MEHA II). This 12-week hybrid initiative is designed to help promising digital health, medtech, and healthcare service ventures scale and reach commercialization faster.
At a Glance
- Opportunity Type: Accelerator Program
- For: Healthcare startups (Digital Health, MedTech, Healthcare Services) addressing key health challenges globally or in the Middle East
- Key Benefits: 12-week hybrid learning, global mentorship, investor exposure, and a Doha immersion week
- Application Deadline: August 17, 2026
- Location: Hybrid (Online / Doha, Qatar)
Accelerator Program Overview
The Cure by Deerfield Middle East Health Accelerator II offers up to 15 selected startup teams a comprehensive 12-week hybrid growth program running from September through late November 2026. Delivered in partnership with Qatar Investment Authority (QIA), Qatar Development Bank (QDB), World Innovation Summit for Health (WISH), and Sidra Medicine, the program aligns with WISH’s core health tracks: healthy longevity, fertility and reproductive health, AI in healthcare, and breakthrough therapies. Participants benefit from live expert mentorship, virtual classes, and online resources, concluding with an in-person immersion week in Doha, Qatar.
Key Benefits
- Hybrid Learning Curriculum: Over 100 hours of curated content, including live virtual sessions, business case studies, and lectures by international experts.
- Global Mentorship: Direct access to experienced mentors across international healthcare and financial sectors.
- Doha Immersion & Pitch Opportunities: Participate in an in-person immersion week in Qatar, pitch to international investors at Demo Day (hosted at Sidra Medicine), and gain exposure at the WISH Summit.
- Ecosystem & Expansion Support: Pathway to establish an operational presence in Qatar, with opportunities to unlock follow-up funding and investor due diligence via partners like Startup Qatar and QDB.
Eligibility Criteria
- Must have a Minimum Viable Product (MVP) or commercialized solution addressing a clear market need in digital health, medical technology, or healthcare services.
- Demonstrated revenue model with sustainable unit economics.
- Willing and able to launch a pilot program in Qatar and travel to Doha for the immersion week.
- Total funding raised must be less than $50 million since inception.
- Must have fewer than 50 full-time employees.
Key Dates and Schedule
- Application Window: July 21 – August 17, 2026
- Cohort Announcement: September 1, 2026
- Program Start: September 8, 2026
- Doha Immersion Week: Week of November 22, 2026
- Demo Day at Sidra Medicine: November 26, 2026
- Winners Announced at WISH: November 29–30, 2026
How to Apply
To join Cohort II of the Cure MEHA program and scale your healthcare solution in the region, submit your application before August 17, 2026.
To submit your application, visit the direct application portal: Cure MEHA Application
About Cure by Deerfield
Cure by Deerfield is a healthcare innovation ecosystem and incubator focused on accelerating the development and commercialization of life-changing medical technologies and digital health solutions. Operating through strategic global partnerships, Cure connects healthcare entrepreneurs with world-class mentors, clinical partners, and institutional investors to address pressing medical challenges worldwide.
Learn More: Cure by Deerfield
